Ketim Technologies Awarded Advance Queensland Ignite Spark Grant to Progress Perinatal Mental Health Diagnostic

Brisbane, Australia – February 12, 2026 – Ketim Technologies has been awarded $75,000 through the Advance Queensland Ignite Spark Program to support the project titled “Industry Integration and Validation for Perinatal Mental Health Blood Test.”

The Ignite Spark Program supports high-potential Queensland innovators progressing commercially viable technologies with strong industry integration pathways.

Funding from the program will accelerate validation activities and strengthen integration with clinical and commercial partners as Ketim advances development of its predictive blood-based diagnostic for postpartum depression.

“This support reinforces the importance of advancing innovation in maternal mental health,” said Dr. Clarissa Yates. “Queensland’s commitment to supporting health and medical technologies enables companies like ours to translate research into real-world clinical solutions.”

The award further validates Ketim’s progress in precision psychiatry and its growing ecosystem of advisors, board members, and early investors, including AngelLoop.

Ketim acknowledges the Queensland Government’s continued investment in mental health innovation and looks forward to progressing its industry integration and validation milestones under the program.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au